JCI Insight - Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
Biotechnology - hACE2 transgenic mouse, animal models for SARS-CoV-2 vaccine- or drug-development (Service provided by A4 Transgenic mouse models core facility) | National Core Facility for Biopharmaceuticals
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection | PNAS
Age associated susceptibility to SARS-CoV-2 infection in the K18-hACE2 transgenic mouse model | GeroScience
COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice | Human Genomics | Full Text
Viruses | Free Full-Text | Virulence Profiles of Wild-Type, P.1 and Delta SARS-CoV-2 Variants in K18-hACE2 Transgenic Mice
A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice - eBioMedicine
COVID-19 K18-hACE2 Transgenic Mouse Model - IITRI
Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5 | Science Advances
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice | Journal of Virology
SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy | bioRxiv
COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice | Nature
Novel transgenic mice with Cre-dependent co-expression of GFP and human ACE2: a safe tool for study of COVID-19 pathogenesis | Transgenic Research
SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapy | bioRxiv
Molecules | Free Full-Text | K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2 - ScienceDirect
Frontiers | Experimental Models of COVID-19
Transgenic hACE2 mice for SARS-CoV-2 and COVID-19 | Taconic Biosciences
SARS-2 protection studies in K18-hACE2 transgenic mice (A) Schematic... | Download Scientific Diagram
Mouse model of fatal COVID-19 developed for vaccine and drug testing
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice | PLOS ONE
034860 - K18-hACE2 Strain Details
hACE2 transgenic mouse model for coronavirus (COVID-19) research
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function | Nature Immunology
